Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral sumatriptan for acute treatment of migraine in children and adolescents
2015-004880-35Phase 3
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in migraine comparing Oral sumatriptan with Placebo (2 arms). Primary endpoint: Pain relief responder rate.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on 2015-004880-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004880-35.